Journal of the American Academy of Dermatology

Diseases, Conditions, Syndromes

Simvastatin / ezetimibe not beneficial in alopecia areata

(HealthDay)—Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the editor published in the May issue of the Journal of the American ...

Diseases, Conditions, Syndromes

Ustekinumab more effective than TNF-alpha inhibitors in psoriasis

(HealthDay)—For patients with psoriasis, ustekinumab is more effective than tumor necrosis factor-α inhibitors, according to a study published in the May issue of the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

Laser plus topical antifungal effective for onychomycosis

(HealthDay)—Fractional carbon dioxide laser therapy combined with topical antifungal is effective in the treatment of onychomycosis, according to a study published in the May issue of the Journal of the American Academy ...

Health

Costs estimated for applying to dermatology residency

(HealthDay)—The total cost for all U.S. medical school seniors applying to dermatology residency is estimated at almost $5 million, according to a research letter published in the April issue of the Journal of the American ...

Diseases, Conditions, Syndromes

Wrestling wins for most high school athletic skin infections

(HealthDay)—Among U.S. high school athletes, the rate of skin infections is 2.27 per 100,000 athlete exposures, with the majority occurring in wrestlers, according to a study published in the April issue of the Journal ...

Diseases, Conditions, Syndromes

Drop in S. aureus carriage rate with antibiotic tx of acne

(HealthDay)—Treatment of acne with antibiotics is associated with a significant decrease in the rate of Staphylococcus aureus carriage, according to a study published in the April issue of the Journal of the American Academy ...

Oncology & Cancer

Melanoma therapy tied to cutaneous adverse events

(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...

page 15 from 25